A. Ribeiro

发表

Use of gemtuzumab ozogamycin combined with conventional chemotherapy in patients with acute myeloid leukemia.

N. Hamerschlak, F. P. Santos, J. Kutner, 2011, Einstein.

Transplantation of Hematopoietic Stem Cells for Primary Immunodeficiencies in Brazil: Challenges in Treating Rare Diseases in Developing Countries

A. Gennery, V. Rocha, N. Hamerschlak, 2018, Journal of Clinical Immunology.

Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation

N. Hamerschlak, F. Kok, J. Kutner, 2018, Bone Marrow Transplantation.

ATG in HLA-matched, peripheral blood, hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome: a secondary analysis of a CIBMTR database.

N. Hamerschlak, L. Kerbauy, L. Arcuri, 2022, Transplantation and cellular therapy.

Need for hemodialysis in patients undergoing hematopoietic stem cell transplantation: risk factors and survival in a retrospective cohort.

N. Hamerschlak, L. Kerbauy, E. Chapchap, 2022, Hematology, transfusion and cell therapy.

Clinical outcomes in allogeneic haematopoietic stem cell transplantation: A comparison between young and elderly patients. Observational study.

N. Hamerschlak, L. Kerbauy, Morgani Rodrigues, 2019, European journal of cancer care.

Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.

A. A. Ribeiro, L. Arcuri, Marina Tayla Mesquita Aguiar, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors for adverse outcomes following haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: a two-center analysis

N. Hamerschlak, L. Kerbauy, A. A. Ribeiro, 2021, Annals of Hematology.

Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in beta thalassemic patients.

A. Araújo, F. Kay, J. Wood, 2012, European journal of radiology.

Severe hemorrhagic cystitis caused by the BK polyomavirus is associated with decreased survival post‐allogeneic hematopoietic stem cell transplantation

N. Hamerschlak, C. Machado, J. Kutner, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Haploidentical non‐myeloablative stem cell transplantation as Salvage for graft failure in a patient with juvenile myelomonocytic leukemia

N. Hamerschlak, M. Torres, G. Perini, 2011, Pediatric Blood & Cancer.

Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning

N. Hamerschlak, M. de Lima, M. Torres, 2011, Leukemia & lymphoma.

Targeted Marrow Irradiation Intensification of Reduced Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation.

R. Sékaly, M. Gallogly, N. Hamerschlak, 2022, Transplantation and cellular therapy.

Autologous Stem Cell Transplantation (ASCT) As Upfront Treatment in Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Comparative Analysis in Clinical Trials Setting

F. Moraes, N. Hamerschlak, F. P. Santos, 2016 .

Long-term safety of photobiomodulation therapy for oral mucositis in hematopoietic cell transplantation patients: a 15-year retrospective study

F. Eduardo, C. Eduardo, N. Hamerschlak, 2021, Supportive Care in Cancer.

Clinical impact of multiple DNA virus infections in nondepleted haploidentical and unrelated allogeneic hematopoietic stem cell transplantation

N. Hamerschlak, C. Machado, L. Kerbauy, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Factors affecting autologous peripheral blood hematopoietic stem cell collections by large-volume leukapheresis: a single center experience.

N. Hamerschlak, J. Kutner, A. Sakashita, 2011, Einstein.

Weight Gain in the First 10 Days after Hematopoietic Stem Cell Transplantation (HSCT) Is a Risk Factor for Early Mortality

P. Campregher, N. Hamerschlak, F. P. Santos, 2014 .

Philadelphia-negative acute lymphoblastic leukemia in a chronic myeloid leukemia patient receiving dasatinib.

N. Hamerschlak, F. P. Santos, Morgani Rodrigues, 2010, Cytotherapy.

Allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiencies: Hospital Israelita Albert Einstein experience.

E. Troster, N. Hamerschlak, J. M. Cunha, 2011, Einstein.

Autologous stem-cell transplantation for multiple myeloma: a Brazilian institution experience in 15 years of follow-up.

N. Hamerschlak, J. Kutner, Morgani Rodrigues, 2011, Einstein.

Posttransplant cyclophosphamide beyond haploidentical transplantation.

N. Hamerschlak, L. Arcuri, A. Ribeiro, 2023, Annals of hematology.

Clinical image: bilateral black eyes (raccoon's eyes) in AL amyloidosis.

N. Hamerschlak, M. Scheinberg, J. Kutner, 2006, Arthritis and rheumatism.

A review of hematopoietic stem cell transplantation for autoimmune diseases: multiple sclerosis, systemic sclerosis and Crohn's disease. Position paper of the Brazilian Society of Bone Marrow Transplantation.

D. Moraes, B. Simões, N. Hamerschlak, 2020 .

Maria-Carolina Oliveira, D. Moraes, B. Simões, 2020, Hematology, transfusion and cell therapy.

Acute Leukemia with M3 Morphology Without Cytogenetic Abnormalities Related to Acute Promyelocytic Leukemia: Description of a Refractory Pediatric Case

N. Hamerschlak, N. Bacal, J. Kutner, 2009 .

Urinary retention after use of decitabine in acute myeloid leukemia: case report

N. Hamerschlak, M. Wroclawski, C. Feres, 2021, Hematology, transfusion and cell therapy.

Axoval neuropathy as initial manifestation of primary amyloidosis: report of a case submitted to bone marrow transplantation.

O. Barsottini, N. Hamerschlak, A. Arantes, 2004, Arquivos de neuro-psiquiatria.